Package 0069-0189-21

Brand: ibrance

Generic: palbociclib
NDC Package

Package Facts

Identity

Package NDC 0069-0189-21
Digits Only 0069018921
Product NDC 0069-0189
Product ID 0069-0189_fb858b80-8bd4-43a6-8871-9819a35ca03f
Description

21 CAPSULE in 1 BOTTLE (0069-0189-21)

Marketing

Marketing Status
Marketed Since 2015-02-03
Brand ibrance
Generic palbociclib
Sample Package No

Linked Drug Pages (1)

Ibrance ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "fb858b80-8bd4-43a6-8871-9819a35ca03f", "openfda": {"nui": ["N0000175605", "N0000175082", "N0000190114"], "upc": ["0300690188218", "0300690189215", "0300690187211"], "unii": ["G9ZF61LE7G"], "rxcui": ["1601380", "1601386", "1601388", "1601390", "1601392", "1601394"], "spl_set_id": ["e0e6412f-50b4-4fd4-9364-62818d121a07"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Kinase Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "21 CAPSULE in 1 BOTTLE (0069-0189-21)", "package_ndc": "0069-0189-21", "marketing_start_date": "20150203"}], "brand_name": "Ibrance", "product_id": "0069-0189_fb858b80-8bd4-43a6-8871-9819a35ca03f", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 3A Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Kinase Inhibitors [MoA]"], "product_ndc": "0069-0189", "generic_name": "palbociclib", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ibrance", "active_ingredients": [{"name": "PALBOCICLIB", "strength": "125 mg/1"}], "application_number": "NDA207103", "marketing_category": "NDA", "marketing_start_date": "20150203", "listing_expiration_date": "20271231"}